Orlando has brought back a version of its classic logo and showed off 3 new uniform looks for next season. Official release Franz Wagner, Jalen Suggs and Paolo Banchero model some of the Magic’s ...

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc.... Atara Biotherapeutics: Q1 Earnings Snapshot SF Gate Logo Hearst Newspapers Logo ...

Workforce reductions are an almost annual occurrence at Atara. The biopharma waved goodbye to 20% of its staff in 2022 and then shrunk its head count by a further 25% last year as it moved its ...

Google’s logo just got a little bit blurrier. In a new logo quietly rolled out across iOS and Pixel, the search giant ditches its color-blocked “G” for gradients.

THOUSAND OAKS, Calif., May 05, 2025--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

Atara Biotherapeutics is halving its head count as it navigates the fallout from the FDA’s move to halt trials of the allogeneic T-cell immunotherapy Ebvallo and a CAR-T candidate.. Atara ...

FDA places a clinical hold on Atara's EBVALLO and ATA3219 programs due to GMP compliance issues at a third-party facility. Atara to pause new participant enrollment; CAR-T programs may suspend in ...

As partners Atara Biotherapeutics and Pierre Fabre Laboratories work to grow the reach of their novel T-cell immunotherapy Ebvallo, a manufacturing-related hitch has tripped up their ambition to la.

Atara remains committed to working with the FDA, Pierre Fabre Laboratories, and the third-party manufacturer to bring EBVALLO to patients in the U.S. Atara has engaged a well-known financial advisor ...

Walmart's new logo on the right. Walmart The new logo will appear on its website and app this month and over time will roll out to its 10,500 stores, which are also in the midst of getting a makeover.

Rodman & Renshaw analyst Tony Buter initiated coverage of Atara Biotherapeutics (ATRA) with a Buy rating and $25 price target Atara is developing T-cell immunotherapies with a focus on the ...